Philippe Van der Linden, MD
CHU Brugmann
3
3
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Arnaud Lechien, MD
CHU Brugmann
Shared therapeutic areas:
Worked with same sponsors:
Van Hecke Delphine, MD
CHU Brugmann
Shared therapeutic areas:
Worked with same sponsors:
Pilar Masdeu, Medicine
IIS La Fe
Shared therapeutic areas:
Dariush Elahi, PhD
Johns Hopkins University
Shared therapeutic areas:
Antonio R Zamunér, PhD
Universidad Católica del Maule
Shared therapeutic areas:
Olfat I Ali, PhD
Cairo University
Shared therapeutic areas:
Noemí Moreno
CLIDET
Shared therapeutic areas:
Şerafettin OKUTAN, PhD.
Bitlis Eren University
Shared therapeutic areas:
Albert Lecube
Sociedad Española para el Estudio de la Obesidad (SEEDO)
Shared therapeutic areas:
Valentina Ivezaj, Ph.D.
Yale University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Does Pulmonary Compliance Optimization Through PEEP Manipulations Reduces the Incidence of Postoperative Hypoxaemia in Bariatric Surgery?
Evaluation of the Minimum Concentration of Tranexamic Acid Required to Inhibit Fibrinolysis in a Population of Pregnant Women at Term.
Comparison of Intraoperative Volume Replacement Determined by the Plethysmograph Variability Index (PVI) With That Determined by the Delta PP in the Digestive, Gynecological, Urological, and Abdominal Surgery and Their Impact on the Length of Stay
All 3 trials loaded